Variational AI
  • Our Approach
  • Company
  • Team
  • Jobs
  • What’s New
  • Blog
  • Contact
  • Read more: Variational AI and Oncocross to Collaborate on AI-Driven Drug Discovery Program in Atopic Dermatitis
    Featured, Press Release

    Variational AI and Oncocross to Collaborate on AI-Driven Drug Discovery Program in Atopic Dermatitis

    Variational AI announces a co-development agreement with Oncocross, to co-develop a novel small molecule inhibitor for chronic skin inflammation focusing on atopic dermatitis.

    Valentin Beuchillot Avatar

    Valentin Beuchillot

    June 19, 2025
  • Read more: Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery
    Featured, Press Release

    Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

    New funding to fuel market expansion of compute efficient foundation model for biopharmaceutical companies

    Handol Kim Avatar

    Handol Kim

    February 20, 2025
  • Read more: Variational AI Selected by ImmVue Therapeutics to Power Immuno-Oncology Drug Discovery
    Featured, Press Release

    Variational AI Selected by ImmVue Therapeutics to Power Immuno-Oncology Drug Discovery

    Immuno-Oncology pioneer ImmVue Therapeutics to adopt Enki™Lead Generator to discover first-in-class cancer drugs.

    Handol Kim Avatar

    Handol Kim

    October 2, 2024
  • Read more: Variational AI and Rakovina announce Collaboration
    Press Release

    Variational AI and Rakovina announce Collaboration

    Rakovina announces potential multi-target engagement with Variational AI focused on DNA Damage Repair (DDR)

    Handol Kim Avatar

    Handol Kim

    September 21, 2024
  • Read more: Variational AI announces generative AI project with Merck
    Press Release

    Variational AI announces generative AI project with Merck

    Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research Labs supported by the CQDM Quantum Leap program.

    Handol Kim Avatar

    Handol Kim

    January 25, 2024
1 2 3
Next Page→

Our Approach

Company

Our Team

What’s New

Blog

Jobs

Contact

Follow Us

  • LinkedIn
  • X

1825 Quebec Street, #201 Vancouver, BC V5T 2Z3 Canada

+1 604 761 7199

info@variational.ai

© Variational AI Inc.

Terms  |  Privacy Policy